HomeInsights52 Week High Stocks

Parenteral Drugs (india) Ltd 52 Week High

Parenteral Drugs (india) Ltd 52 Week High

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Aug 21, 2023)

stocks purchased

1.3 K

Stocks Traded

(Aug 21, 2023)

Last Updated on: Nov 15, 2024

Image

Parenteral Drugs (India) Ltd

NSE: PDPL

YEARHIGH

₹ -

Last updated on: Aug 21, 2024

Key Highlights

  • The 52 Week HIGH of Parenteral Drugs (India) Ltd is ₹ 0 as of 21 Aug 23.

Company Fundamentals for Parenteral Drugs (India) Ltd

No data available

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Parenteral Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Aug 20233.39
14 Aug 20233.24
24 Jul 20233.09
17 Jul 20233.25
10 Jul 20233.42
03 Jul 20233.59
26 Jun 20233.77
19 Jun 20233.96
12 Jun 20233.85
05 Jun 20234.05

Asset Value vs Market Value of Parenteral Drugs (India) Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Parenteral Drugs (India) Ltd News Hub

News

Parenteral Drugs (India) to conduct board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 3...

Read more

19 May 202215:25

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

05 Feb 202215:19

News

Parenteral Drugs (India) to convene EGM

Parenteral Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Com...

Read more

03 Feb 202216:49

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 2...

Read more

31 Jan 202211:36

News

Parenteral Drugs (India) to hold board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

06 Nov 202116:34

News

Parenteral Drugs (India) AGM scheduled

Parenteral Drugs (India) announced that the 37th Annual General Meeting (AGM) of the compa...

Read more

27 Aug 202114:27

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Parenteral Drugs (India) Ltd

What is the significance of Parenteral Drugs (India) Ltd reaching its 52-week high?

Parenteral Drugs (India) Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Parenteral Drugs (India) Ltd 52-week high?

Investors monitor Parenteral Drugs (India) Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Parenteral Drugs (India) Ltd a good buy when it hits its 52-week high?

Whether Parenteral Drugs (India) Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Parenteral Drugs (India) Ltd fundamentals.

What should I consider before investing in Parenteral Drugs (India) Ltd at its 52-week high?

Before investing in Parenteral Drugs (India) Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Parenteral Drugs (India) Ltd stock price continue to rise after reaching its 52-week high?

Parenteral Drugs (India) Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*